The left ventricular mechanical dispersion as a marker of disease severity in transthyretin cardiac amyloidosis

Transthyretin amyloidosis (ATTR) is a fatal disorder, thus early detection of cardiac involvement is crucial for improved clinical outcomes. This study investigated the utility of left ventricular (LV) speckle-tracking-derived mechanical dispersion as a potential marker for the assessment of cardiac amyloidosis (CA) in patients with ATTR and their first-degree relatives. This prospective, single-centre study enrolled 100 adults from 2020 to 2024 (ClinicalTrials NCT05814380). Participants underwent clinical assessment, genetic testing, and [<sup>99m</sup>Tc]Tc-DPD SPECT/CT. Global longitudinal strain (GLS) and mechanical dispersion were evaluated using speckle-tracking echocardiography. Patients with ATTR CA exhibited significantly impaired GLS and increased mechanical dispersion (p < 0.001). Mechanical dispersion exhibited correlations with age, New York Heart Association class, LV mass index, E/E', LV ejection fraction, GLS, levels of N-terminal pro-brain natriuretic peptide and Perugini grade (p < 0.05 for all). In univariable Cox regression, mechanical dispersion (Hazard ratio (HR) = 1.03, 95% confidence intervals (CI) 1.01-1.06, p = 0.004), normalised to heart rate mechanical dispersion (HR = 1.43, 95% CI 1.14-1.81, p = 0.002) were significant predictors of all-cause mortality. In our study increased mechanical dispersion was associated with advanced disease stages and mortality. These findings suggest that it may serve as a marker of ATTR CA.Registration: ClinicalTrials.gov Identifier: NCT05814380.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2025-11-27
DOI
https://doi.org/10.1038/s41598-025-26329-x
Primary Topic
Amyloidosis: Diagnosis, Treatment, Outcomes
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The left ventricular mechanical dispersion as a marker of disease severity in transthyretin cardiac amyloidosis

Krystian Mróz, Andrzej Ząbek, Maria Kurek, Piotr Podolec et al.
Scientific Reports
Amyloidosis: Diagnosis, Treatment, Outcomes
article

The left ventricular mechanical dispersion as a marker of disease severity in transthyretin cardiac amyloidosis

Krystian Mróz, Andrzej Ząbek, Maria Kurek, Piotr Podolec, Katarzyna Holcman, Bogdan Ćmiel, Magdalena Kostkiewicz, Katarzyna Graczyk, Paweł Rubiś, Sylwia Szczepara, Krzysztof Boczar, Karolina Gutkowska, Ewa Dziewięcka, Agnieszka Stępień-Wroniecka, Winiarczyk Mateusz
article en

Abstract

Transthyretin amyloidosis (ATTR) is a fatal disorder, thus early detection of cardiac involvement is crucial for improved clinical outcomes. This study investigated the utility of left ventricular (LV) speckle-tracking-derived mechanical dispersion as a potential marker for the assessment of cardiac amyloidosis (CA) in patients with ATTR and their first-degree relatives. This prospective, single-centre study enrolled 100 adults from 2020 to 2024 (ClinicalTrials NCT05814380). Participants underwent clinical assessment, genetic testing, and [<sup>99m</sup>Tc]Tc-DPD SPECT/CT. Global longitudinal strain (GLS) and mechanical dispersion were evaluated using speckle-tracking echocardiography. Patients with ATTR CA exhibited significantly impaired GLS and increased mechanical dispersion (p < 0.001). Mechanical dispersion exhibited correlations with age, New York Heart Association class, LV mass index, E/E', LV ejection fraction, GLS, levels of N-terminal pro-brain natriuretic peptide and Perugini grade (p < 0.05 for all). In univariable Cox regression, mechanical dispersion (Hazard ratio (HR) = 1.03, 95% confidence intervals (CI) 1.01-1.06, p = 0.004), normalised to heart rate mechanical dispersion (HR = 1.43, 95% CI 1.14-1.81, p = 0.002) were significant predictors of all-cause mortality. In our study increased mechanical dispersion was associated with advanced disease stages and mortality. These findings suggest that it may serve as a marker of ATTR CA.Registration: ClinicalTrials.gov Identifier: NCT05814380.

Scientific ReportsVol. 15(1)
Jagiellonian University (PL), John Paul II Hospital (PL), AGH University of Krakow (PL)
Pfizer
Openalex Percentile: Top 67%
Amyloidosis: Diagnosis, Treatment, Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.